Neuphoria Therapeutics's total assets for Q3 2026 were AU$34.81M, a decrease of -4.89% from the previous quarter. NEUP total liabilities were AU$5.39M for the fiscal quarter, a -21.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.